000			04225nam a22004215c 4500
710	2		_aSpringerLink (Online service) _9106996
999			_c112957 _d112957 _x1
001			112957
003			ES-MaUEC
005			20230102113552.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			190502s2019 gw a o |||| 0|eng d
020			_a9783030048617
024	7		_a10.1007/978-3-030-04861-7 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC280.S8 _b2019 EB
245	0	0	_aGastric Cancer In The Precision Medicine Era. _bDiagnosis and Therapy _cedited by Vincenzo Canzonieri, Antonio Giordano.
264		1	_aCham _bSpringer International Publishing : _bImprint: Humana _c2019.
300			_aXV, 256 páginas 47 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	1		_aCurrent Clinical Pathology _x2197-781X
490	0		_aMedicine (Springer-11650)
505	0		_aGastric Tumorigenesis: Role of Inflammation and Helicobacter Pylori -- Genetic and Epigenetic Mechanisms in Gastric Cancer -- Diagnosis and Surveillance: Endoscopic Hallmarks -- Pathological Diagnosis And Classification Of Gastric Epithelial Tumors -- Diagnostic, Prognostic, Predictive and Therapeutic Tissue Biomarkers in Gastric Cancer -- Serum Biomarkers in Gastric Cancer -- New Agents in the treatment of Advanced Gastric Cancer: Targeted Therapy and Immunotherapy -- Combined-Modality Treatment for Locally Advanced Gastric Cancer: Current Evidences and New Perspectives -- Surgical Strategies in Gastric Cancer -- From Molecular Classification to Targeted Therapy for Gastric Cancer in the Precision Medicine Era -- Non-Coding RNA in Gastric Cancer with Potential Prognostic and Predictive Role -- Immunomodulation and Immunotherapy for Gastric Cancer -- Nanomedicine in Gastric Cancer.
520	3		_aThis book provides a comprehensive, state-of-the art review and serves as an overview of the different aspects of gastric cancer. The first section aims to clarify the main aspects of tumorigenesis, such as the role of inflammation linked to the presence of H. Pylori infection, and the genetic and epigenetic mechanisms so far known. Secondly, an exhaustive overview of the diagnosis of gastric cancer from a clinical/endoscopic and pathologic perspective will be illustrated. The second section includes the pathological and clinical features and contains information regarding the most recent tissue and serological biomarkers in these neoplasms. The three successive sections are intended to provide the "state of art" of multimodal treatment approaches to gastric cancer, i.e. standard and novel surgical aspects, common and innovative chemo and radio protocols and modern targeted therapies. Novel molecular classifications are under consideration to improve diagnostic and prognostic definitions and to prospect future treatments based on the use of immunotherapies and innovative molecules such as non-coding RNA and nanoparticles. Gastric Cancer in the Precision Medicine Era serves as a useful resource for physicians and researchers dealing with, and interested in, this challenging malignancy. It provides a concise yet comprehensive summary of the current status of the field that helps guide patient management and stimulates investigative efforts. All chapters are written by experts in their fields and includes the most up to date scientific and clinical information.
988			_aSpringer_Medicine_2019
650		7	_2embne _aEstómago _xCáncer _9670603
700	1		_aCanzonieri, Vincenzo. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aGiordano, Antonio. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _926701
776	0	8	_iPrinted edition: _z9783030048600
776	0	8	_iPrinted edition: _z9783030048624
830		0	_aCurrent Clinical Pathology, _x2197-781X _9133628
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-04861-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_dz _feng _ggw _h0 _b09/2019 _ek _zSI